Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2794-2797

  Knecht, Rainald ^a   Elez, Robert ^a   Oechler, Martin ^a   Solbach, Christine ^a   Von Ilberg, Christoph ^a   Strebhardt, Klaus ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; DIAGNOSTIC VALUE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033564832     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Parkin, D. M. Laara, E., and Muir, C. S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41: 184-197, 1988.
2. Muscat, J. E., and Wynder, E. L. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer (Phila.), 69: 2244-2251, 1992.
3. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 47: 5-27, 1997.
4. Lane, H. A., and Nigg, E. A. Cell-cycle control: polo-like kinases join the outer circle. Cell Biol., 7: 63-68, 1997.
5. Descombes, P., and Nigg, E. A. The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts. EMBO J., 17: 1328-1335, 1998.
6. Shirayama, M., Zachariae, W., Ciosk, R., and Nasmyth, K. The polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae. EMBO J., 17: 1336-1349, 1998.
7. Holtrich, U., Wolf, G., Bräuninger, A., Karn, T., Böhme, B., Rübsamen-Waigmann, H., and Strebhardt, K. Induction and down-regulation of PLK, a human serine/ threonine kinase expressed in proliferating cells and tumors. Proc. Natl. Acad. Sci. USA, 91: 1736-1740, 1994.
8. Wolf, G., Elez, R., Doermer, A., Holtrich, U., Ackermann, H., Stutte, H. J., Altmannsberger, H. M., Rübsamen-Waigmann H., and Strebhardt, K. Prognostic significance of polo-like (PLK) expression in non-small cell lung cancer. Oncogene, 14: 543-549, 1997.
9. Yuan, J., Hörlin, A., Stutte, H. J., Rübsamen-Waigmann, H., and Strebhardt, K. Polo-like kinase, a novel marker for cellular proliferation. Am. J. Pathol., 150: 1165-1172, 1997.
10. Medina, J. E. A rational classification of neck dissections. Otolaryngol. Head Neck Surg., 100: 169-176, 1989.
11. Forastiere, A., Metch, A., Schuller, B., and Moses, B. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck. A Southwest Oncology group study. J. Clin. Oncol., 10: 1245-1251, 1992.
12. Myers, J. N. Molecular pathogenesis of squamous cell carcinoma of the head and reck. In: E. N. Myers and J. Y. Suen (eds.), Cancer of the Head and Neck, pp. 5-16. Philadelphia: W. B. Saunders, 1996.
13. Shin, D. M., Voravud, N., Ro, J. Y., Lee, J. S., Hong, W. K., and Hittelmann, W. N. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J. Natl. Cancer Inst., 85: 971-978, 1993.
14. Lampe, H. P. DNA analysis of head and neck squamous cell carcinoma by flow cytometry. Laryngoscope, 103: 637-644, 1993.
15. Kearsley, J. H., Furlong, K. L., Cook, R. A., and Waters, M. J. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br. J. Cancer, 61: 821-827, 1990.
16. Raybaud, D. H., Fortin, A., Morency, R., Roy, J., Monteil, R. A., and Tetu, B. Markers of radioresistance in squamous cell carcinoma of the head and neck: a clinicopathologic and immunohistochemical study. J. Clin. Oncol., 15: 1030-1038, 1997.
17. Wenz, F., Lohr, F., Flentje, M., Rudat, V., Dietz, A., and Wannemacher, M. Predictive value of the flow cytometric PCNA assay in head and neck tumors after accelerated- hyperfractionated radiochemotherapy. Int. J. Radiol. Oncol., 37: 771-776, 1997.
18. Roland, N. J., Caslin, A. W., Bowie, G. L., and Jones, A. S. Has the cellular proliferation marker Ki 67 any clinical relevance in squamous cell carcinoma of the head and neck. Clin. Otolaryngol., 19: 13-18, 1994.
19. Sommer, T., and Olofsson, J. Significance of p53, PCNA and Ki67 in the prognosis of squamous cell carcinoma of the oral cavity. Laryngo-Rhino-Otol., 76: 189-196, 1997.